Reaction
Pelvic Neoplasm reporting signals
As of the last recalculation, Pelvic Neoplasm appears in 344 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is LANREOTIDE ACETATE (PRR 121.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lanreotide Acetate | 15 | 121.0 | 121.2 |
| Loperamide Hydrochloride Oral | 9 | 54.7 | 54.8 |
| Loperamide Hcl | 9 | 43.4 | 43.5 |
| Niraparib | 15 | 42.7 | 42.7 |
| Ado-Trastuzumab Emtansine | 4 | 29.0 | 29.0 |
| Rucaparib | 3 | 20.7 | 20.7 |